/SENS
SENS Stock - Senseonics Holdings, Inc.
Healthcare|Medical - DevicesNASDAQ
$6.15-1.13%
$0.07 (-1.13%) • Dec 19
27
GoAI Score
GoAI Score
Weighted average: Momentum (25%) + Sentiment (35%) + Risk (20%) + Value (20%). ≥70 = BUY, ≤35 = SELL.SELL
Medium Confidence
Momentum
Momentum Score
Based on price vs 50-day MA (40%), 200-day MA (40%), and MA crossover (20%). Higher = stronger uptrend.1
Sentiment
Sentiment Score
Based on analyst price target upside. 50 = neutral, 100 = very bullish (25%+ upside expected).0
Risk Score
Risk Score
Based on stock beta (volatility). Higher score = lower risk. Red (<40) = high volatility, Green (>60) = stable.83
Price Target
Price Target
Average analyst price target from the last quarter. Shows expected upside/downside from current price.+-82.1%upside
Target: $1.10
AI Analysis PreviewPremium
Real-time AI-powered market analysis
Precise entry/exit price targets
Risk assessment & position sizing
Unlock GoAI Insights for SENS
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Buy/Sell Signals
94% win rate on Alpha signals
Deep Analysis
Institutional-grade thesis
Real-Time Alerts
SMS & push notifications
Risk Scoring
Multi-factor analysis
Free 14-day trial • No credit card required
Active Trade Setup
ENTRY ZONE$6.09 – $6.21
TARGET (TP)$1.10
STOP LOSS$5.66
RISK/REWARD1:-10.3
Premium members get real-time SMS alerts
Price Chart
Financial Statements
Revenue & Profitability Trend
← Swipe to see more →
Revenue
Net Income (Profit)
Net Loss
Key Metrics
Market CapN/A
P/E RatioN/A
Beta0.93
52W High$28.00
52W Low$5.25
Avg VolumeN/A
Income Statement (Fiscal Year)
| Metric | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Revenue | $22.47M | $22.39M | $16.39M | $13.68M | $4.95M |
| Gross Profit | $533,000 | $3.09M | $2.73M | $-811,000 | $-17,366,000 |
| Gross Margin | 2.4% | 13.8% | 16.6% | -5.9% | -350.9% |
| Operating Income | $-74,842,000 | $-75,603,000 | $-68,627,000 | $-57,182,000 | $-79,130,000 |
| Net Income | $-78,616,000 | $-60,392,000 | $142.12M | $-302,474,000 | $-175,168,000 |
| Net Margin | -349.8% | -269.7% | 867.2% | -2211.9% | -3539.5% |
| EPS | $-2.50 | $-2.20 | $6.00 | $-14.40 | $-15.40 |
Company Overview
Senseonics Holdings, Inc., a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes in the United States, Europe, the Middle East, and Africa. The company's products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes through an under-the-skin sensor, a removable and rechargeable smart transmitter, and a convenient app for real-time diabetes monitoring and management for a period of up to six months. It serves healthcare providers and patients through a network of distributors and strategic fulfillment partners. The company has a collaboration agreement with the University Hospitals Accountable Care Organization. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.
Visit WebsiteRating Distribution
Strong Buy
0%
Buy / Outperform
3
60%
Hold / Neutral
1
20%
Sell / Underperform
1
20%
Analyst Consensus🟡 Mixed
3 Bullish2 Neutral/Bearish
Price Targets
$3
Average Target
↓ 58.4% Downside
Now
$1
Low
$3
Average
$9
High
Based on 6 analysts
Recent Analyst Actions
| Date | Firm | Action | Rating | Price Target |
|---|---|---|---|---|
| October 21st 2025 | Stifel | Resumed | Hold | $9 |
| August 27th 2025 | Barclays | Initiation | Overweight | $1.5 |
| July 15th 2025 | TD Cowen | Initiation | Buy | $1.25 |
| June 2nd 2025 | H.C. Wainwright | Resumed | Buy | $1.1 |
| April 10th 2025 | Mizuho | Initiation | Outperform | $2 |
| July 19th 2023 | Jefferies | Initiation | Underperform | $0.5 |
Earnings History & Surprises
SENSBeat Rate
22%
Last 18 quarters
Avg Surprise
-50.4%
EPS vs Estimate
Beats / Misses
4/11
3 met exactly
Latest EPS
$-0.43
Q4 2025
EPS Surprise History
Q1 24
-29.1%
$-0.03vs$-0.02
Q2 24
0.0%
$-0.03vs$-0.03
Q3 24
-2.4%
$-0.03vs$-0.03
Q4 24
-17.6%
$-0.04vs$-0.03
Q1 25
+33.3%
$-0.02vs$-0.03
Q2 25
0.0%
$-0.02vs$-0.02
Q3 25
0.0%
$-0.40vs$-0.40
Q4 25
-30.3%
$-0.43vs$-0.33
Beat Estimate
Missed Estimate
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q2 2026 | May 6, 2026 | — | — | — | — |
Q1 2026 | Mar 2, 2026 | $-0.43 | — | — | — |
Q4 2025 | Nov 5, 2025 | $-0.33 | $-0.43 | -30.3% | ✗ MISS |
Q3 2025 | Aug 6, 2025 | $-0.40 | $-0.40 | 0.0% | = MET |
Q2 2025 | May 8, 2025 | $-0.02 | $-0.02 | 0.0% | = MET |
Q1 2025 | Mar 3, 2025 | $-0.03 | $-0.02 | +33.3% | ✓ BEAT |
Q4 2024 | Nov 7, 2024 | $-0.03 | $-0.04 | -17.6% | ✗ MISS |
Q3 2024 | Aug 8, 2024 | $-0.03 | $-0.03 | -2.4% | ✗ MISS |
Q2 2024 | May 13, 2024 | $-0.03 | $-0.03 | 0.0% | = MET |
Q1 2024 | Feb 29, 2024 | $-0.02 | $-0.03 | -29.1% | ✗ MISS |
Q4 2023 | Nov 9, 2023 | $-0.04 | $-0.04 | -14.3% | ✗ MISS |
Q3 2023 | Aug 10, 2023 | $-0.04 | $-0.04 | -3.2% | ✗ MISS |
Q2 2023 | May 9, 2023 | $-0.03 | $-0.03 | -20.0% | ✗ MISS |
Q1 2023 | Mar 15, 2023 | $-0.05 | $-0.01 | +80.0% | ✓ BEAT |
Q4 2022 | Nov 8, 2022 | $-0.04 | $-0.13 | -205.9% | ✗ MISS |
Q3 2022 | Aug 9, 2022 | $-0.02 | $-0.03 | -29.4% | ✗ MISS |
Q2 2022 | May 10, 2022 | $-0.03 | $-0.03 | -14.3% | ✗ MISS |
Q1 2022 | Mar 1, 2022 | $0.00 | $0.01 | +762.1% | ✓ BEAT |
Q4 2021 | Nov 9, 2021 | $-0.07 | $-0.03 | +57.1% | ✓ BEAT |
Q3 2021 | Aug 9, 2021 | $-0.00 | $-0.05 | -1472.3% | ✗ MISS |
Latest News
Senseonics Announces Transfer Of Nasdaq Stock Exchange, Effective After Close On Nov. 14
➖ NeutralBenzinga•Nov 10, 2025, 01:07 PM
Senseonics down as 2025 guidance trails consensus
📉 NegativeSeeking Alpha•Nov 6, 2025, 04:43 PM
HC Wainwright & Co. Maintains Buy on Senseonics Holdings, Raises Price Target to $18.5
📈 PositiveBenzinga•Nov 6, 2025, 12:20 PM
Senseonics Holdings Narrows FY2025 Sales Guidance from $34.000M-$38.000M to $35.000M vs $35.928M Est
➖ NeutralBenzinga•Nov 5, 2025, 09:22 PM
Senseonics Holdings Q3 EPS $(0.43) Misses $(0.32) Estimate, Sales $8.095M Beat $7.965M Estimate
➖ NeutralBenzinga•Nov 5, 2025, 09:21 PM
TD Cowen Maintains Buy on Senseonics Holdings, Lowers Price Target to $15
➖ NeutralBenzinga•Nov 5, 2025, 06:41 PM
Stifel Reinstates Hold on Senseonics Holdings, Announces $9 Price Target
➖ NeutralBenzinga•Oct 21, 2025, 02:12 PM•Also:
Senseonics Holdings Authorizes Shares Reduction From 1.4B To 70M
📈 PositiveBenzinga•Oct 16, 2025, 08:23 PM
Senseonics Holdings shares are trading lower after the company announced preliminary Q3 unaudited revenue results. Also, the company announced a 1-for-20 reverse stock split.
📉 NegativeBenzinga•Oct 7, 2025, 03:32 PM
Senseonics Announces Preliminary Unaudited Revenue For Q3 2025 Of $8.1M And Announced 1-For-20 Reverse Stock Spilt Anticipated To Be Effective October 17, 2025.
➖ NeutralBenzinga•Oct 6, 2025, 08:16 PM
Senseonics Holdings Expects FY 2025 Global Net Revenue To Be ~ $34M-$38M
➖ NeutralBenzinga•Sep 3, 2025, 09:23 PM
Senseonics Holdings Memorandum Of Understanding To Transition All Commercialization And Distribution Of Eversense 365 And Future Products From Ascensia Diabetes Care; Non-dilutive Debt Facility Expanded Up To $100M With Hercules Capital To Fund Commercial Organization
📈 PositiveBenzinga•Sep 3, 2025, 09:22 PM•Also:
Barclays Initiates Coverage On Senseonics Holdings with Overweight Rating, Announces Price Target of $1.5
📈 PositiveBenzinga•Aug 27, 2025, 06:20 PM•Also:
Humacyte, Senseonics jump as Barclays issues new Overweight ratings
📈 PositiveSeeking Alpha•Aug 27, 2025, 02:24 PM•Also: ,
Frequently Asked Questions about SENS
What is SENS's current stock price?
Senseonics Holdings, Inc. (SENS) is currently trading at $6.15 per share. The stock has moved -1.13% today.
What is the analyst price target for SENS?
The average analyst price target for SENS is $1.10, based on 1 analyst.
What sector is Senseonics Holdings, Inc. in?
Senseonics Holdings, Inc. operates in the Healthcare sector, specifically within the Medical - Devices industry. The company is traded on the NASDAQ exchange.
What is SENS's market cap?
Senseonics Holdings, Inc. has a market capitalization of $0.25 billion, making it a small-cap company.
Does SENS pay dividends?
No, Senseonics Holdings, Inc. does not currently pay a dividend to shareholders.
Similar Stocks
Healthcare SectorACRS
Aclaris Therapeutics, Inc.
$3.14
Mkt Cap: $0.3B
CAPR
Capricor Therapeutics, Inc.
$27.81
Mkt Cap: $1.3B
CERS
Cerus Corporation
$2.09
Mkt Cap: $0.4B
CVRX
CVRx, Inc.
$8.03
Mkt Cap: $0.2B
MASS
908 Devices Inc.
$5.84
Mkt Cap: $0.2B
NNOX
Nano-X Imaging Ltd.
$2.99
Mkt Cap: $0.2B
NPCE
NeuroPace, Inc.
$16.59
Mkt Cap: $0.6B
QTRX
Quanterix Corporation
$6.59
Mkt Cap: $0.3B
SGHT
Sight Sciences, Inc.
$8.45
Mkt Cap: $0.4B
SNWV
SANUWAVE Health, Inc.
$32.25
Mkt Cap: $0.3B
Explore stocks similar to SENS for comparison